Potassium is the major cation of intracellular fluid and an almost constant component of lean body tissues. A high intracellular concentration of potassium is maintained by the Na+/K+-ATPase pump. The movements of potassium out of cells and sodium into cells changes the electrical potential during depolarisation and repolarisation of nerve and muscle cells.
Leafy green vegetables, vine fruit such as tomatoes, cucumbers, zucchini, eggplant and pumpkin, and root vegetables are particularly good sources of potassium. It is also moderately abundant in beans and peas, tree fruits such as apples, oranges and bananas, milks and yoghurts and meats. In unprocessed foods, potassium occurs mainly with bicarbonate-generators like citrate. Potassium added during processing is generally as potassium chloride. About 85% of potassium is absorbed (Holbrook et al 1984).
Most of the ingested potassium (80-90%) is excreted in urine, the rest being excreted in faeces and sweat (Holbrook et al 1984, Pietinen 1982). Potassium filtered in the glomeruli of the kidney is mostly reabsorbed. The potassium in urine results from secretion into the cortical collecting duct under control of the hormone, aldosterone. High plasma levels of potassium stimulate release of aldosterone to increase the secretion of potassium.
Potassium requirements can be affected by climate and physical activity, the use of diuretics, and the intake of other electrolytes, notably sodium. Potassium blunts the effect of sodium chloride on blood pressure, mitigating salt sensitivity and lowering urinary calcium excretion (Whelton et al 1997). Given this interrelatedness, requirement for potassium depends to some extent on dietary sodium, however, the ideal sodium:potassium intake ratio is not sufficiently established to use in setting requirements.
It has been hypothesised that high protein-low potassium diets could induce a low-grade metabolic acidosis that could induce demineralisation of bone, osteoporosis and kidney stones (Barzel 1995, Lemann et al 1999) and epidemiological and metabolic studies have supported this suggestion (Maurer et al 2003, Morris et al 2001, New et al 1997, Sebastian et al 1994, Tucker et al 1999).
Potential indicators for potassium requirements include potassium balance, serum potassium and clinical endpoints, such as the levels required to avoid hypokalemia, high blood pressure, cardiovascular disease, bone demineralisation or kidney stones. However, dose-response trials are either not available for many of these endpoints, or are insufficient to estimate average requirements.
1 mmol potassium = 39 mg potassium
Recommendations by life stage and gender
|0-6 months||400 mg/day||(10 mmol)|
|7-12 months||700 mg/day||(18 mmol)|
Rationale: The AI for 0-6 months was calculated by multiplying the average intake of breast milk (0.78 L/day) by the average concentration of potassium (500 mg/L), and rounding. For 7-12 months, an average breast milk volume of 0.6 L/day and concentration of 500 mg/L give an intake of 300 mg/day, to which is added 440 mg/day from complementary foods as determined by the US CSFII survey (FNB:IOM 2004).
Children & adolescents
|1-3 yr||2,000 mg/day||(50 mmol)|
|4-8 yr||2,300 mg/day||(60 mmol)|
|9-13 yr||3,000 mg/day||(76 mmol)|
|14-18 yr||3,600 mg/day||(92 mmol)|
|9-13 yr||2,500 mg/day||(64 mmol)|
|14-18 yr||2,600 mg/day||(66 mmol)|
Rationale: There is very little evidence about requirements in children. The recommendations are derived from the intakes from the appropriate age group data from the Australian (ABS 1998) and New Zealand (MOH 2003) National Nutrition Surveys on a population-weighted basis.
|19-30 yr||3,800 mg/day||(100 mmol)|
|31-50 yr||3,800 mg/day||(100 mmol)|
|51-70 yr||3,800 mg/day||(100 mmol)|
|>70 yr||3,800 mg/day||(100 mmol)|
|19-30 yr||2,800 mg/day||(72 mmol)|
|31-50 yr||2,800 mg/day||(72 mmol)|
|51-70 yr||2,800 mg/day||(72 mmol)|
|>70 yr||2,800 mg/day||(72 mmol)|
Rationale: Whilst there are some experimental data on potassium intakes in relation to blunting of salt sensitivity (Morris et al 1999b) and some supportive epidemiological evidence on renal stones (Curhan et al 1993, 1997, Hirvonen et al 1999) these were considered insufficient basis for setting an AI as the sodium blunting experiment was carried out in males only and much of the key data related to salt sensitive African American males. The AI was therefore set at the highest median intake for the various age categories of adult males and females.
|14-18 yr||2,800 mg/day||(72 mmol)|
|19-30 yr||2,800 mg/day||(72 mmol)|
|31-50 yr||2,800 mg/day||(72 mmol)|
Rationale: Potassium accretion in pregnancy is small, so the AI is set at the same level as that for adult females.
|14-18 yr||3,200 mg/day||(82 mmol)|
|19-30 yr||3,200 mg/day||(82 mmol)|
|31-50 yr||3,200 mg/day||(82 mmol)|
Rationale: The lactation AI is set at that for adult females plus an allowance for potassium secreted in breast milk.
Upper Level of Intake
No ULs have been set for potassium from dietary sources.
For infants 0-12 months, the source of intake should be breast milk, formula and food only. For children, adolescents and adults, including pregnant and lactating women, supplements should be taken only under medical supervision.
Rationale: High potassium intakes can cause gastrointestinal discomfort and stress that may include ulceration and perforation (Lambert & Newman 1980, Leijonmarck & Raf 1985, Pietro & Davidson 1990, Sinar et al 1986). Arrhythmia can also arise from the resulting hyperkalaemia (Haddad & Strong 1975, Kallen et al 1976, Snyder et al 1975, Su et al 2001, Ray et al 1999, Wetli & Davis 1978).
However, in otherwise healthy people, there have been no reports of hyperkalaemia from acute or chronic ingestion of potassium in naturally occurring in food, so a UL for foods has not been set.
Because of its well-documented potential for toxicity, supplemental potassium should only be provided under medical supervision. For infants, intake should be limited to potassium occurring in breast milk, formula and complementary foods.
Australian Bureau of Statistics: Department of Health and Aged Care; National nutrition survey. Nutrient intakes and physical measurements. Australia, 1995. Canberra: Australian Bureau of Statistics, 1998.
Barzel US. The skeleton as an ion exchange system: implications for the role of acid-base imbalance in the genesis of osteoporosis. J Bone Min Res 1995;10:1431-6.
Curhan GC, Willett WEC, Rimm ER, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 1993;328:833-8.
Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk of kidney stones in women. Ann Intern Med 1997;126:497-04.
Food and Nutrition Board:Institute of Medicine. Dietary Reference Intakes for water, potassium, sodium, chloride and sulfate. Panel on the dietary reference intakes for electrolytes and water. Washington, DC: National Academy Press, 2004.
Haddad A, Strong E. Potassium in salt substitutes. N Engl J Med 1975;292:1082.
Hirvonen T, Pietinen P, Virtanen M, Albanes D, Virtamo J. Nutrient intake and use of beverages and the risk of kidney stones among male smokers. Am J Epidemiol 1999;150:187-94.
Holbrook JT, Patterson KY, Bodner JE, Douglas LW, Veillon C, Kelsay JL, Mertz W, Smith JC. Sodium and potassium intake and balance in adults consuming self-selected diets. Am J Clin Nutr 1984;40:786-93.
Kallen RJ, Reiger CHL, Cohen HS, Suter MA, Ong RT. Near-fatal hyperkalemia due to ingestion of salt substitute by an infant. JAMA 1976;235:2125-6.
Lambert JR, Newman A. Ulceration and stricture of the oesophagus due to potassium chloride (slow release tablet) therapy. Am J Gastroenterol 1980;73:508-11.
Leijonmarck CE, Raf L. Gastrointestinal lesions and potassium chloride supplements. Lancet 1985;1:56-7.
Lemann J. Relationship between urinary calcium and net acid excretion as determined by dietary protein and potassium: a review. Nephron 1999;81:18S-25S.
Maurer M, Reisen W, Muser J, Hulter HN, Krapf R. Neutralisation of Western diets inhibits bone resorption independently of K intake and reduces cortisol secretion in humans. Am J Physiol Renal Physiol 2003;284:F32-F40.
Morris RC Jnr, Sebastian A, Formon A, Tanaka M, Schmidlin O. Normotensive salt-sensitivity: effects of race and dietary potassium. Hypertension 1999;33:18-23.
Morris RC Jnr, Frassetto LA, Schmidlin O, Forman A, Sebastian A. Expression of osteoporosis as determined by diet-induced electrolyte and acid-base metabolism. In: Burckhardt PB, Dawson-Hughes B, Heaney RP eds, Nutritional Aspects of Osteoporosis. San Diego, CA: Academic Press, 2001. Pp 357-78.
New SA, Bolton-Smith C, Grubb DA, Reid DM. Nutritional influences on bone mineral density: a cross-sectional study in postmenopausal women. Am J Clin Nutr 1997;65:1831-9.
Pietinen P. Estimating sodium intake from food composition data. Ann Nutr Metab 1982;26:90-9.
Pietro DA, Davidson L. Evaluation of patients' preference of two potassium chloride supplements. Slow-K and K-Dur. Clin Ther 1990;12:431-5.
Ray KK, Dorman S, Watson RDS. Severe hyperkalemia due to the concomitant use of salt substitutes and ACE inhibitors in hypertension: a potentially life threatening interaction. J Hum Hypertens 1999;13:717-20.
Sebastian A, Harris ST, Ottaway JH, Todd KM, Morris RC Jnr. Improved mineral balance and skeletal metabolism in postmenopausal women treated with potassium bicarbonate. N Engl J Med 1994;330:1776-81.
Sinar DR, Bozymski EM, Blackshar JL. Effects of oral potassium supplements on upper gastrointestinal mucosa: a multicenter clinical comparison of three formulations and placebo. Clin Ther 1986;8:157-63.
Snyder EL, Dixon T, Bresnitz E. Abuse of salt substitutes. New Engl J Med 1975;292:1082.
Su M, Stork C, Ravuri S, Lavoie T, Anguish D, Nelson LS, Hoffman RS. Sustained-release potassium chloride overdose. J Toxicol Clin Toxicol 2001;39:641-8.
Tucker KL, Hannan MT, Chen H, Cupples LA, Wilson PWF, Kiel DP. Potassium, magnesium and fruit and vegetable intakes are associated with greater bone mineral density in elderly men and women. Am J Clin Nutr 1999;69:727-36.
Wetli CV, Davis JH. Fatal hyperkalemia from accidental overdose of potassium chloride. JAMA 1978;240:1339.
Whelton PK, He J, Cutler JA, Brancati FL, Appel LJ, Follmann D, Klag MJ. Effects of oral potassium on blood pressure: meta-analysis of randomised controlled clinical trials. JAMA 1997;277:1624-32.